Anat Polyachenko

Anat represents emerging to mature life sciences companies, as well as private equity and venture capital funds. She advises on a broad range of corporate and transactional affairs, including licensing transactions, collaboration agreements, strategic alliances, joint ventures, cross-border mergers and acquisitions and equity investments. Anat also handles contractual arrangements for drug discovery, research, development, manufacturing and supply, and commercialization of new products.